Several life saving medicines, including for heart disease, high blood pressure, and diabetes, are now up to 30% cheaper in India. The National Pharmaceutical Pricing Authority (NPPA) has fixed the new rates for these drugs, following a review of their prices.

According to the NPPA, the price reduction will benefit patients who require these drugs on a long-term basis. The new rates will apply to both branded and generic versions of these drugs, and the price reduction will vary depending on the type of drug and its strength.

Some of the drugs that will see a significant price reduction include Atorvastatin, which is used to treat high cholesterol, and Metformin, which is used to treat diabetes. The prices of several drugs used to treat heart disease, including Ramipril and Losartan, have also been reduced.

The NPPA has stated that the new prices will be implemented immediately, and pharmaceutical companies will have to comply with the new rates. This move is expected to provide relief to patients who need these drugs on a regular basis, particularly those who come from low-income households.